MedPath

To find out predictors of failure of High Flow Nasal Cannula Oxygen therapy in children.

Not Applicable
Conditions
Health Condition 1: J962- Acute and chronic respiratory failure
Registration Number
CTRI/2021/03/032301
Lead Sponsor
Maulana Azad Medical College and associated Lok Nayak Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All children 1 month to 12 years of age started on HFNC therapy.

Exclusion Criteria

Children having underlying Cyanotic heart diseases

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Impact of initial SpO2/FiO2 ratio on failure of HFNC therapy in children.Timepoint: O hours (initial, at time of admission in PICU)
Secondary Outcome Measures
NameTimeMethod
1.Impact of degree of improvement seen at 2 hours and 6 hours in SpO2/FiO2 ratio and Respiratory Clinical Score (RCS) on failure of HFNC therapy in children. <br/ ><br>2.Effect of other factors like age, underlying disease etiology and disease severity (by PRISM III score) on failure of HFNC therapy. <br/ ><br>Timepoint: 2 hours and 6 hours
© Copyright 2025. All Rights Reserved by MedPath